|Institutional Source||Beutler Lab|
|Gene Name||polycystic kidney disease 2|
|Synonyms||C030034P18Rik, TRPP2, polycystin-2, PC2|
|Is this an essential gene?||Essential (E-score: 1.000)|
|Stock #||R2163 (G1)|
|Chromosomal Location||104459450-104505819 bp(+) (GRCm38)|
|Type of Mutation||unclassified|
|DNA Base Change (assembly)||T to C at 104455677 bp|
|Amino Acid Change|
|Ref Sequence||ENSEMBL: ENSMUSP00000084041 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000086831]|
AA Change: T62A
|Predicted Effect||probably benign
|Predicted Effect||noncoding transcript
|Meta Mutation Damage Score||0.0476|
|Coding Region Coverage||
|Validation Efficiency||97% (76/78)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a member of the polycystin protein family. The encoded protein is a multi-pass membrane protein that functions as a calcium permeable cation channel, and is involved in calcium transport and calcium signaling in renal epithelial cells. This protein interacts with polycystin 1, and they may be partners in a common signaling cascade involved in tubular morphogenesis. Mutations in this gene are associated with autosomal dominant polycystic kidney disease type 2. [provided by RefSeq, Mar 2011]
PHENOTYPE: Homozygotes for targeted null mutations exhibit defects in cardiac septation, kidney and pancreatic cysts, impaired left-right axis determination, and late-gestation lethality. Heterozygotes show kidney and liver lesions and have reduced longevity. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Pkd2||
(F):5'- TATTCACGGGGACAATCTCTCC -3'
(R):5'- AATCTTTTGTCATAGAGCTGGACC -3'
(F):5'- GGGGACAATCTCTCCAACAAG -3'
(R):5'- CATAGAGCTGGACCTTTCCTGG -3'